Doerge D R, Decker C J
Division of Biochemical Toxicology, National Center for Toxicological Research, Jefferson, Arkansas 72079.
Chem Res Toxicol. 1994 Mar-Apr;7(2):164-9. doi: 10.1021/tx00038a008.
Sulfonamide antibiotics, typified by sulfamethazine (SMZ), are widely used in veterinary practice. Sulfonamide residues in milk and meat products are of regulatory concern since SMZ is a thyroid carcinogen in rodents and sulfonamide-induced hypersensitivity reactions, including hypothyroidism, have been reported in humans. SMZ and other primary arylamines inhibited iodination reactions catalyzed by thyroid peroxidase (TPO) and the closely related lactoperoxidase (LPO). Inhibition of LPO-catalyzed triiodide ion formation by SMZ and other primary arylamines was complex as both apparent Km and Vmax values were affected, but consistent with a rapid equilibrium binding mechanism. The apparent Ki for SMZ inhibition of TPO- and LPO-catalyzed iodide ion oxidation was approximately 0.42 and 0.11 mM, respectively. The corresponding Ki values for a series of para-substituted anilines correlated with the ease of one-electron N-oxidation as measured by ionization potentials determined from semiempirical molecular orbital calculations. The aniline derivatives containing electron-donating substituents (e.g., p-CH3, p-OEt, p-Cl) were converted by LPO to colored products characteristic of one-electron oxidation. However, sulfonamides were not consumed in such reactions nor were any N-oxygenated derivatives formed in the absence of ascorbate (e.g., hydroxylamino, nitroso, nitro, azoxy). These observations suggest that the primary mechanism for sulfonamide-induced hypothyroidism is reversible inhibition of TPO-mediated thyroid hormone synthesis and not the formation and covalent binding of reactive N-oxygenated metabolites. These results are consistent with a hormonal mechanism for SMZ-induced thyroid carcinogenesis mediated by thyroid-stimulating hormone (TSH).(ABSTRACT TRUNCATED AT 250 WORDS)
以磺胺二甲嘧啶(SMZ)为代表的磺胺类抗生素在兽医实践中广泛使用。牛奶和肉制品中的磺胺类残留受到监管关注,因为SMZ在啮齿动物中是一种甲状腺致癌物,并且在人类中已报告有磺胺类诱导的超敏反应,包括甲状腺功能减退。SMZ和其他伯芳胺抑制甲状腺过氧化物酶(TPO)和密切相关的乳过氧化物酶(LPO)催化的碘化反应。SMZ和其他伯芳胺对LPO催化的三碘离子形成的抑制作用很复杂,因为表观Km和Vmax值均受到影响,但与快速平衡结合机制一致。SMZ抑制TPO和LPO催化的碘离子氧化的表观Ki分别约为0.42和0.11 mM。一系列对取代苯胺的相应Ki值与通过半经验分子轨道计算确定的电离势测量的单电子N-氧化的难易程度相关。含有供电子取代基(例如,对-CH3、对-OEt、对-Cl)的苯胺衍生物被LPO转化为单电子氧化特征的有色产物。然而,在这些反应中磺胺类未被消耗,并且在没有抗坏血酸的情况下也没有形成任何N-氧化衍生物(例如,羟氨基、亚硝基、硝基、偶氮氧基)。这些观察结果表明,磺胺类诱导甲状腺功能减退的主要机制是TPO介导的甲状腺激素合成的可逆抑制,而不是活性N-氧化代谢物的形成和共价结合。这些结果与促甲状腺激素(TSH)介导的SMZ诱导甲状腺癌发生的激素机制一致。(摘要截断于250字)